CONNECT Trademark

Trademark Overview

On Friday, November 9, 2018, a trademark application was filed for CONNECT with the United States Patent and Trademark Office. The USPTO has given the CONNECT trademark a serial number of 88188096. The federal status of this trademark filing is REGISTERED as of Tuesday, September 24, 2019. This trademark is owned by UCB Biopharma SPRL. The CONNECT trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, injector devices for pharmaceutical products in the field of immunology disorders and/or central nervous system disorders
connect

General Information

Serial Number88188096
Word MarkCONNECT
Filing DateFriday, November 9, 2018
Status700 - REGISTERED
Status DateTuesday, September 24, 2019
Registration Number5866064
Registration DateTuesday, September 24, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Description of MarkThe mark consists of the word "connect" in which the letter "o" is comprised of a sound wave design featuring a dot and three concentric semicircles.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical devices, namely, injector devices for pharmaceutical products in the field of immunology disorders and/or central nervous system disorders

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB BIOPHARMA SRL
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressBrussels B-1070
BE
Party NameUCB Biopharma SPRL
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressB-1070 Brussels
BE
Party NameUCB Biopharma SPRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressB-1070 Brussels
BE
Party NameUCB Biopharma SPRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressB-1070 Brussels
BE

Trademark Events

Event DateEvent Description
Wednesday, January 16, 2019NON-FINAL ACTION WRITTEN
Tuesday, November 13, 2018NEW APPLICATION ENTERED
Tuesday, November 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 28, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 20, 2018ASSIGNED TO EXAMINER
Tuesday, January 15, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 28, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 6, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 16, 2019NON-FINAL ACTION E-MAILED
Wednesday, January 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 3, 2019ASSIGNED TO LIE
Tuesday, June 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 5, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, May 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 11, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 12, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, September 24, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 12, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Related Keywords

connect disorders devices central system immunology nervous products namely injector pharmaceutical